|
Pronunciation |
|
(po
do FIL
oks) |
|
|
U.S. Brand
Names |
|
Condylox® |
|
|
Generic
Available |
|
No |
|
|
Pharmacological Index |
|
Keratolytic Agent; Topical Skin Product |
|
|
Use |
|
Treatment of external genital warts |
|
|
Pregnancy Risk
Factor |
|
C |
|
|
Usual Dosage |
|
Adults: Apply twice daily (morning and evening) for 3 consecutive days, then
withhold use for 4 consecutive days; this cycle may be repeated up to 4 times
until there is no visible wart tissue |
|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |
|
|
Dental Health:
Effects on Dental Treatment |
|
No effects or complications reported |
|
|
Patient
Information |
|
Apply to warts with a cotton-tipped applicator supplied with the drug,
dispose carefully after use; allow the solution to dry before allowing the
return of opposing skin surfaces to their normal positions; wash hands after
application |
|
|
Nursing
Implications |
|
Apply to warts with a cotton-tipped applicator supplied with the drug,
dispose carefully after use; allow the solution to dry before allowing the
return of opposing skin surfaces to their normal positions; wash hands after
application |
|
|
Dosage Forms |
|
Solution, topical: 0.5% (3.5
mL) |
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|